ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 351 filers reported holding ENCOMPASS HEALTH CORP in Q1 2018. The put-call ratio across all filers is 0.27 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $5,164,386 | -37.5% | 95,460 | -30.9% | 0.02% | -42.5% |
| Q4 2022 | $8,261,735 | +17.1% | 138,133 | -11.5% | 0.04% | +8.1% |
| Q3 2022 | $7,058,000 | -39.5% | 156,042 | -25.0% | 0.04% | -35.1% |
| Q2 2022 | $11,660,000 | +791.4% | 208,023 | +1030.6% | 0.06% | +1040.0% |
| Q1 2022 | $1,308,000 | +8.9% | 18,400 | 0.0% | 0.01% | +25.0% |
| Q4 2021 | $1,201,000 | -93.7% | 18,400 | -92.7% | 0.00% | -95.4% |
| Q3 2021 | $18,968,000 | +4.1% | 252,777 | +8.3% | 0.09% | +8.8% |
| Q2 2021 | $18,220,000 | +317.8% | 233,496 | +230.4% | 0.08% | +196.3% |
| Q4 2018 | $4,361,000 | -43.1% | 70,675 | -28.1% | 0.03% | -32.5% |
| Q3 2018 | $7,662,000 | -17.5% | 98,300 | -28.3% | 0.04% | -21.6% |
| Q2 2018 | $9,286,000 | +10.6% | 137,117 | -6.6% | 0.05% | +6.2% |
| Q1 2018 | $8,396,000 | – | 146,857 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BARINGTON CAPITAL GROUP, L.P. | 76,809 | $4,155,367 | 5.68% |
| Paradice Investment Management LLC | 850,583 | $46,016,540 | 3.50% |
| BERNZOTT CAPITAL ADVISORS | 273,702 | $14,807,278 | 3.06% |
| Orchard Capital Management, LLC | 135,466 | $7,328,711 | 2.45% |
| Advantage Alpha Capital Partners LP | 202,232 | $10,940,751 | 2.28% |
| REINHART PARTNERS, LLC. | 746,588 | $40,390,419 | 2.19% |
| Magnetar Financial LLC | 1,917,030 | $103,711,323 | 2.02% |
| Leeward Investments, LLC - MA | 700,894 | $37,918,365 | 1.73% |
| HEARTLAND ADVISORS INC | 505,204 | $27,331,536 | 1.69% |
| Copeland Capital Management, LLC | 1,226,985 | $66,380 | 1.56% |